Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price traded down 6.3% on Tuesday . The company traded as low as GBX 1.50 and last traded at GBX 1.50. 237,187 shares traded hands during trading, a decline of 81% from the average session volume of 1,269,613 shares. The stock had previously closed at GBX 1.60.
Cizzle Biotechnology Price Performance
The company’s fifty day simple moving average is GBX 1.57 and its 200-day simple moving average is GBX 1.59. The firm has a market capitalization of £5.95 million, a PE ratio of -4.69 and a beta of 0.38.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last released its earnings results on Tuesday, September 30th. The company reported GBX (0.09) EPS for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- The 3 Best Retail Stocks to Shop for in August
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- Industrial Products Stocks Investing
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
- Dividend Capture Strategy: What You Need to Know
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
